AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Olopatadine Hydrochloride Equivalent To Olopatadine

9 registrations across 1 African market— 9 active

Markets with Olopatadine Hydrochloride Equivalent To Olopatadine

Recent registrations

Brand / ProductMarketHolderStatusExpires
OLOPATADINE EYE DROPS FDC🇿🇦South AfricaFDC SA (Pty) LtdactiveMar 2030
OLOVIS🇿🇦South AfricaFDC SA (Pty) LtdactiveMar 2030
ZYLOPAT🇿🇦South AfricaFDC SA (Pty) LtdactiveMar 2030
CONALAP🇿🇦South AfricaRanbaxy Pharmaceutical (Pty) LtdactiveAug 2027
OLOPATADINE CLICKS🇿🇦South AfricaUnicorn Pharmaceuticals (Pty) LtdactiveJan 1900
OLOPATADINE EYE DROPS PHARMA-Q🇿🇦South AfricaPharma-Q Holdings (Pty) LtdactiveJan 1900
ALLODROP🇿🇦South AfricaiPharma (Pty) LtdactiveJan 1900
PATANOL🇿🇦South AfricaNovartis South Africa (Pty) LtdactiveJan 1900
OLOPAGEN🇿🇦South AfricaGen-Eye (Pty) LtdactiveJan 1900

Olopatadine Hydrochloride Equivalent To Olopatadine in Africa — Regulatory Overview

Olopatadine Hydrochloride Equivalent To Olopatadine is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.